KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy

Oncology Reports

Volumn 32, Issue 4, 2014, Pages 1419-1426

  Yamane, L S ^a   Scapulatempo Neto, C ^a   Alvarenga, L ^a   Oliveira, C Z ^a   Berardinelli, G N ^a   Almodova, E ^a   Cunha, T R ^a   Fava, G ^a   Colaiacovo, W ^a   Melani, A ^a   Fregnani, J H ^a   Reis, R M ^a,b   Guimarães, Denise Peixoto ^a  

^a BARRETOS CANCER HOSPITAL   (Brazil)

^b UNIVERSITY OF MINHO   (Portugal)

Author keywords

Adenoma; BRAF; Colorectal cancer; KRAS; Microsatellite instability; Serrated polyp

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

ADULT; AGED; ARTICLE; BRAF GENE; BRAZIL; CANCER STAGING; CARCINOGENESIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASTIC POLYP; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; ONCOGENE K RAS; PRECANCER; PRIORITY JOURNAL; RECTUM ADENOMA; TUMOR DIFFERENTIATION; VERY ELDERLY; ADENOCARCINOMA; ADENOMA; COLON POLYP; COLORECTAL TUMOR; GENETICS; MUTATION; PATHOLOGY;

ADENOCARCINOMA; ADENOMA; AGED; AGED, 80 AND OVER; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS;

EID: 84923068430     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3338     Document Type: Article

References (35)

1. Brasil. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Coordenação Geral de Ações Estratégicas. Coordenação de Prevenção e Vigilância: Estimativa 2012: incidência de câncer no Brasil. INCA, Rio de Janeiro, 2011 (In Portuguese).
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
4. Goss PE, Lee BL, Badovinac-Crnjevic T, et al: Planning cancer control in Latin America and the Caribbean. Lancet Oncol 14: 391-436, 2013.
5. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
6. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H and Chejfec G: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343: 162-168, 2000. (Pubitemid 30489212)
7. Leggett B and Whitehall V: Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138: 2088-2100, 2010.
8. Tuppurainen K, Makinen JM, Junttila O, et al: Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol 207: 285-294, 2005. (Pubitemid 41556452)
9. Yamane L, Scapulatempo-Neto C, Reis RM and Guimarães DP: Serrated pathway in colorectal carcinogenesis. World J Gastroenterol 20: 2634-2640, 2014.
10. Garcia-Solano J, Perez-Guillermo M, Conesa-Zamora P, et al: Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol 41: 1359-1368, 2010.
11. Rex DK: Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc 51: 33-36, 2000.
12. Imperiale TF and Ransohoff DF: Understanding differences in the guidelines for colorectal cancer screening. Gastroenterology 138: 1642-1647, 2010.
13. Laghi L and Malesci A: Microsatellite instability and therapeutic consequences in colorectal cancer. Dig Dis 30: 304-309, 2012.
14. Vilar E and Gruber SB: Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol 7: 153-162, 2010.
15. Sebolt-Leopold JS and Herrera R: Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4: 937-947, 2004. (Pubitemid 39626217)
16. Kudo S, Lambert R, Allen JI, et al: Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 68: S3-S47, 2008.
17. Bosman FT, Carneiro F, Hruban RH, Theise ND (eds): IARC WHO Classification of Tumours of the Digestive System. 4th edition. IARC Press, Lyon, 2010.
18. Valadao M, Braggio D, Santos AF, et al: Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients. J Surg Res 178: 288-293, 2012.
19. Martinho O, Gouveia A, Viana-Pereira M, et al: Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Histopathology 55: 53-62, 2009.
20. Campanella NC, Berardinelli GN, Scapulatempo-Neto C, et al: Optimization of a pentaplex panel for MSI analysis without control DNA in a Brazilian population: correlation with ancestry markers. Eur J Hum Genet 22: 875-880, 2014.
21. Carr NJ, Mahajan H, Tan KL, Hawkins NJ and Ward RL: Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 62: 516-518, 2009.
22. Bariol C, Hawkins NJ, Turner JJ, Meagher AP, Williams DB and Ward RL: Histopathological and clinical evaluation of serrated adenomas of the colon and rectum. Mod Pathol 16: 417-423, 2003. (Pubitemid 36618461)
23. Kahi CJ, Hewett DG, Norton DL, Eckert GJ and Rex DK: Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 9: 42-46, 2011.
24. Spring KJ, Zhao ZZ, Karamatic R, et al: High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131: 1400-1407, 2006. (Pubitemid 44708940)
25. Iino H, Jass JR, Simms LA, et al: DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol 52: 5-9, 1999. (Pubitemid 29023500)
26. Tadepalli US, Feihel D, Miller KM, et al: A morphologic analysis of sessile serrated polyps observed during routine colonoscopy (with video). Gastrointest Endosc 74: 1360-1368, 2011.
27. Mäkinen MJ: Colorectal serrated adenocarcinoma. Histopathology 50: 131-150, 2007.
28. Groff RJ, Nash R and Ahnen DJ: Significance of serrated polyps of the colon. Curr Gastroenterol Rep 10: 490-498, 2008.
29. Rex DK, Ahnen DJ, Baron JA, et al: Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 107: 1315-1329, 2012.
30. Winawer SJ, Zauber AG, Fletcher RH, et al: Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 130: 1872-1885, 2006. (Pubitemid 43668826)
31. Torlakovic E and Snover DC: Serrated adenomatous polyposis in humans. Gastroenterology 110: 748-755, 1996. (Pubitemid 26071842)
32. Torlakovic E, Skovlund E, Snover DC, Torlakovic G and Nesland JM: Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27: 65-81, 2003. (Pubitemid 36014900)
33. Yadamsuren EA, Nagy S, Pajor L, Lacza A and Bogner B: Characteristics of advanced- and non advanced sporadic polypoid colorectal adenomas: correlation to KRAS mutations. Pathol Oncol Res 18: 1077-1084, 2012.
34. Yang S, Farraye FA, Mack C, Posnik O and O'Brien MJ: BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 28: 1452-1459, 2004. (Pubitemid 39425511)
35. Rad R, Cadinanos J, Rad L, et al: A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention. Cancer Cell 24: 15-29, 2013.